Australia's most trusted
source of pharma news
Posted 14 October 2025 AM
Middle managers have copped the brunt of downsizing across pharma, branded as bureaucrats and blamed for slowing companies down, but experts are warning that sacking them could be a big mistake.
A study published in the Journal of Management Studies, co-authored by Monash Business School Professor of Strategy & International Business, Mariano Heyden, said middle managers hold a vital position in companies as a nexus for both informational and social interactions in companies.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.